80 related articles for article (PubMed ID: 9709910)
1. Color Doppler sonography patterns related to histological findings in Graves' disease.
Morosini PP; Simonella G; Mancini V; Argalia G; Lucarelli F; Montironi R; Diamanti L; Suraci V
Thyroid; 1998 Jul; 8(7):577-82. PubMed ID: 9709910
[TBL] [Abstract][Full Text] [Related]
2. [Doppler color ultrasonography in the diagnosis of diffuse hyperthyroidism].
Argalia G; Mignosi U; Lucarelli F; Morosini PP; Aglieri V; Giuseppetti GM
Radiol Med; 1997; 93(1-2):61-6. PubMed ID: 9380870
[TBL] [Abstract][Full Text] [Related]
3. [Graves' disease: ultrasonographic, color Doppler and histological aspects].
Messina G; Viceconti N; Trinti B
Recenti Prog Med; 1997 Nov; 88(11):513-6. PubMed ID: 9446154
[TBL] [Abstract][Full Text] [Related]
4. Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves' disease and diffuse toxic goiter.
Saleh A; Cohnen M; Fürst G; Godehardt E; Mödder U; Feldkamp J
Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):32-6. PubMed ID: 11835123
[TBL] [Abstract][Full Text] [Related]
5. Thyroid vascularization by color doppler ultrasonography in Graves' disease. Changes related to different phases and to the long-term outcome of the disease.
Baldini M; Castagnone D; Rivolta R; Meroni L; Pappalettera M; Cantalamessa L
Thyroid; 1997 Dec; 7(6):823-8. PubMed ID: 9459623
[TBL] [Abstract][Full Text] [Related]
6. [Role of flowmetric analysis and of color-Doppler ultrasonography with contrast media in the different phases and follow-up of Graves' disease].
Amodio F; Di Martino S; Esposito S; Iorio S; Hierholzer J; Rea G; Bizzarro A; Vallone G
Radiol Med; 2001 Oct; 102(4):233-7. PubMed ID: 11740450
[TBL] [Abstract][Full Text] [Related]
7. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
[TBL] [Abstract][Full Text] [Related]
8. Color Doppler sonography in Graves' disease: value in assessing activity of disease and predicting outcome.
Castagnone D; Rivolta R; Rescalli S; Baldini MI; Tozzi R; Cantalamessa L
AJR Am J Roentgenol; 1996 Jan; 166(1):203-7. PubMed ID: 8571877
[TBL] [Abstract][Full Text] [Related]
9. Utility of colour Doppler sonography in patients with Graves' disease.
Kumar KV; Vamsikrishna P; Verma A; Muthukrishnan J; Rayudu BR; Modi KD
West Indian Med J; 2009 Dec; 58(6):566-70. PubMed ID: 20583684
[TBL] [Abstract][Full Text] [Related]
10. The usefulness of conventional and echo colour Doppler sonography in the differential diagnosis of toxic multinodular goitres.
Boi F; Loy M; Piga M; Serra A; Atzeni F; Mariotti S
Eur J Endocrinol; 2000 Sep; 143(3):339-46. PubMed ID: 11022175
[TBL] [Abstract][Full Text] [Related]
11. Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period.
Carella C; Mazziotti G; Sorvillo F; Piscopo M; Cioffi M; Pilla P; Nersita R; Iorio S; Amato G; Braverman LE; Roti E
Thyroid; 2006 Mar; 16(3):295-302. PubMed ID: 16571093
[TBL] [Abstract][Full Text] [Related]
12. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
Meller J; Jauho A; Hüfner M; Gratz S; Becker W
Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
[TBL] [Abstract][Full Text] [Related]
13. Color-flow Doppler sonography in Graves disease: "thyroid inferno".
Ralls PW; Mayekawa DS; Lee KP; Colletti PM; Radin DR; Boswell WD; Halls JM
AJR Am J Roentgenol; 1988 Apr; 150(4):781-4. PubMed ID: 3279732
[TBL] [Abstract][Full Text] [Related]
14. [The clinical and laboratory findings in Graves' multinodular type disease].
Grammaticos P; Vasiliou O; Papanastasiou E; Gerasimou G; Balaris V; Alexandris R; Liaros G; Dedousi E
Hell J Nucl Med; 2006; 9(1):53-9. PubMed ID: 16617399
[TBL] [Abstract][Full Text] [Related]
15. Thyroid histology of hyperthyroid Graves' disease with undetectable thyrotropin receptor antibodies.
Kawai K; Tamai H; Mori T; Morita T; Matsubayashi S; Katayama S; Kuma K; Kumagai LF
J Clin Endocrinol Metab; 1993 Sep; 77(3):716-9. PubMed ID: 7690362
[TBL] [Abstract][Full Text] [Related]
16. [Role of Doppler color ultrasonography and of flowmetric analysis in the diagnosis and follow-up of Grave's disease].
Sponza M; Fabris B; Bertolotto M; Ricci C; Armini L
Radiol Med; 1997 Apr; 93(4):405-9. PubMed ID: 9244919
[TBL] [Abstract][Full Text] [Related]
17. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
18. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease.
Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y
Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404
[TBL] [Abstract][Full Text] [Related]
19. Color Doppler measurement of blood flow in the inferior thyroid artery in patients with autoimmune thyroid diseases.
Caruso G; Attard M; Caronia A; Lagalla R
Eur J Radiol; 2000 Oct; 36(1):5-10. PubMed ID: 10996751
[TBL] [Abstract][Full Text] [Related]
20. Decreased serum level of IL-7 in patients with active Graves' disease.
Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
